C

Cell Biotech Co Ltd
KOSDAQ:049960

Watchlist Manager
Cell Biotech Co Ltd
KOSDAQ:049960
Watchlist
Price: 13 220 KRW 0.99% Market Closed
Market Cap: ₩90.5B

Net Margin

24.9%
Current
Improving
by 7.2%
vs 3-y average of 17.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
24.9%
=
Net Income
₩12.6B
/
Revenue
₩50.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
24.9%
=
Net Income
₩12.6B
/
Revenue
₩50.6B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Cell Biotech Co Ltd
KOSDAQ:049960
90.5B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
394.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...

Market Distribution

Higher than 95% of companies in Korea
Percentile
95th
Based on 2 632 companies
95th percentile
24.9%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Cell Biotech Co Ltd
Glance View

Market Cap
90.5B KRW
Industry
Biotechnology

Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. The company is headquartered in Gimpo, Gyeonggi-Do. The company went IPO on 2002-12-13. The firm's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The firm distributes its products within domestic market and to overseas markets.

Cell Biotech Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
24.9%
=
Net Income
₩12.6B
/
Revenue
₩50.6B
What is Cell Biotech Co Ltd's current Net Margin?

The current Net Margin for Cell Biotech Co Ltd is 24.9%, which is above its 3-year median of 17.7%.

How has Net Margin changed over time?

Over the last 3 years, Cell Biotech Co Ltd’s Net Margin has decreased from 30% to 24.9%. During this period, it reached a low of 0.3% on Sep 30, 2023 and a high of 30.3% on Dec 31, 2024.

Back to Top